Back to Lung Cancer
This trial is complete. It is no longer accepting participants. Results may be available on ClinicalTrials.gov.

NCT04640870

NCT04640870
Completed Not Applicable

Who may be able to join

Who might be able to join this trial:

  • You are older than 18 years of age
  • You have been diagnosed with a type of lung cancer called non-small cell lung cancer
  • Your cancer has spread to other parts of the body (metastatic disease)
  • You have been treated with a drug called Afatinib at some point during your cancer treatment
  • Your cancer has a specific change (mutation) in a gene called EGFR

Who may not be able to join:

  • No specific exclusion criteria have been listed for this trial (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

Trial details

Status
Completed
Phase
Not Applicable
Sponsor
Hellenic Cooperative Oncology Group
Registry
clinicaltrials_gov
Start date
15 March 2015
Est. completion
1 March 2020

Primary endpoints

Progression Free Survival

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

View original record on ClinicalTrials.gov